QNRX

$6.90-3.50%

Quoin Pharmaceuticals, Ltd.

Market Cap

$491M

Sector

Materials

Industry

Biotechnology

Beta

1.69

5yr monthly vs SPY

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

8

recent articles

Analyst Consensus

Strong Buy

10 analysts

Velocity Score

25.65x

Current Rate (90d)

409.78/mo

Baseline Rate

0.00/mo

Unique Buyers (90d)

3

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-08-31	2026-09-01	Culverwell Anthony James	Director	Purchase	6,146	$4.88	$30K	40.4K	View
2026-08-31	2026-09-01	Carter Denise P.	Director & Chief Operating Officer	Purchase	20.5K	$4.88	$100K	37.7K	View
2026-08-31	2026-09-01	Lawlor Sally Bridget	Chief Financial Officer	Purchase	10.2K	$4.88	$50K	10.7K	View

Recent News

Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU

Yahoo Finance · 2026-09-10

CORRECTION -- Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome

Yahoo Finance · 2026-09-08

Quoin in line for priority review voucher if rare paediatric drug approved

Yahoo Finance · 2026-09-08

Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million

Informational purposes only, not investment advice.